You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Mauro Maniglio1, Moaath Saggaf2, Nupur Purohit3
1Department of Hand Surgery, The Balgrist, University Clinic, 8008 Zürich, Switzerland.
Two plasma biomarkers, PIIANP and Visfatin, can predict treatment outcomes for trapeziometacarpal (TM) osteoarthritis (OA). PIIANP indicates improvement, while Visfatin suggests worsening of TM OA symptoms one year post-treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: